126 related articles for article (PubMed ID: 7123508)
1. [Plasmapheresis in normal donors ].
Frey-Wettstein M
Ther Umsch; 1982 Jul; 39(7):551-4. PubMed ID: 7123508
[No Abstract] [Full Text] [Related]
2. The development of plasma derivatives in Switzerland.
Kistler P
Vox Sang; 1972; 23(1):26-31. PubMed ID: 5081011
[No Abstract] [Full Text] [Related]
3. Plasma fractionation in England and Wales.
Vallet L
Vox Sang; 1972; 23(1):58-60. PubMed ID: 4628157
[No Abstract] [Full Text] [Related]
4. The current status of blood fractionation in the United States.
Sgouris JT
Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014
[No Abstract] [Full Text] [Related]
5. Factors determining quality of plasma.
Myllylä G
Vox Sang; 1998; 74 Suppl 2():507-11. PubMed ID: 9704491
[No Abstract] [Full Text] [Related]
6. Notes on plasma derivative production in the Federal Republic of Germany.
Schwick HG
Vox Sang; 1972; 23(1):44. PubMed ID: 5081013
[No Abstract] [Full Text] [Related]
7. Selective plasmapheresis using special secondary on line filters in therapy of immune disorders.
Siami G; Stone WJ
Prog Clin Biol Res; 1990; 337():355-7. PubMed ID: 2352994
[No Abstract] [Full Text] [Related]
8. [Effect of long-term plasmapheresis on blood composition. I. Changes in the concentration of total proteins, electrophoretic fractions and immunoglobulins].
Grgicević D; Pende B
Bilt Hematol Transfuz; 1981; 9(1-3):77-88. PubMed ID: 7349761
[TBL] [Abstract][Full Text] [Related]
9. [Blood transfusion 1975].
Hässig A
Z Krankenpfl; 1975 Nov; 68(11):312-6. PubMed ID: 1043566
[No Abstract] [Full Text] [Related]
10. [Precipitation plasmapheresis and its automated system].
Saito A; Takagi T
Nihon Rinsho; 1991 Dec; 49 Suppl():612-7. PubMed ID: 1808325
[No Abstract] [Full Text] [Related]
11. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
[TBL] [Abstract][Full Text] [Related]
12. Improvement in plasma protein clearance in a model membrane plasma separator employing sequential haemodilution and ultrafiltration.
Fisher AC
Life Support Syst; 1985; 3 Suppl 1():359-64. PubMed ID: 3870594
[No Abstract] [Full Text] [Related]
13. Plasmapheresis and cytapheresis.
Nosé Y; Gurland HJ; Klein HG; Malchesky PS; Ota K
Trans Am Soc Artif Intern Organs; 1982; 28():631-8. PubMed ID: 7164316
[No Abstract] [Full Text] [Related]
14. Experiences in the development of plasma derivatives in Japan.
Naito R
Vox Sang; 1972; 23(1):35-7. PubMed ID: 4117047
[No Abstract] [Full Text] [Related]
15. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
[TBL] [Abstract][Full Text] [Related]
16. [Problems in plasmapheresis (transfusions and clinical aspects)].
Fiala J
Vnitr Lek; 1981 Nov; 27(11):1131-6. PubMed ID: 7314553
[No Abstract] [Full Text] [Related]
17. [A novel procedure for accomplishing step-wise plasmapheresis. Experimental studies and clinical application].
von Baeyer H; Kochinke F
Biomed Tech (Berl); 1983 Jun; 28(6):137-44. PubMed ID: 6882855
[No Abstract] [Full Text] [Related]
18. Management of plasmapheresis in France.
Cazenave JP; Folléa G
Hematol Cell Ther; 1996 May; 38 Suppl 1():S25-33. PubMed ID: 8933144
[TBL] [Abstract][Full Text] [Related]
19. [Possibilities of therapeutic plasmapheresis].
Neppert J
Beitr Infusionther Klin Ernahr; 1979; (3):53-65. PubMed ID: 575885
[No Abstract] [Full Text] [Related]
20. Decreased ionized calcium during therapeutic plasma exchange pheresis and platelet pheresis.
Morse EE; Hohnadel DC; Genco P; Katz AJ
Johns Hopkins Med J; 1980 Jun; 146(6):260-3. PubMed ID: 7382251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
